CU23948B1 - COMPOUNDS AND COMPOSITIONS AS MODULATORS OF TLR ACTIVITY - Google Patents

COMPOUNDS AND COMPOSITIONS AS MODULATORS OF TLR ACTIVITY

Info

Publication number
CU23948B1
CU23948B1 CU2010000176A CU20100176A CU23948B1 CU 23948 B1 CU23948 B1 CU 23948B1 CU 2010000176 A CU2010000176 A CU 2010000176A CU 20100176 A CU20100176 A CU 20100176A CU 23948 B1 CU23948 B1 CU 23948B1
Authority
CU
Cuba
Prior art keywords
compounds
compositions
modulators
compound
tlr activity
Prior art date
Application number
CU2010000176A
Other languages
Spanish (es)
Other versions
CU20100176A7 (en
Inventor
Tom Yao-Hsiang Wu
Yongkai Li
Alex Cortez
Yefen Zou
Pranab Mishra
Xiaoyue Zhang
David Skibinski
Manmohan Singh
Nicholas Valiante
Original Assignee
Novartis Ag
Irm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2009/035563 external-priority patent/WO2009111337A1/en
Application filed by Novartis Ag, Irm filed Critical Novartis Ag
Publication of CU20100176A7 publication Critical patent/CU20100176A7/en
Publication of CU23948B1 publication Critical patent/CU23948B1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Un compuesto de la fórmula (I-A), o una sal aceptable para uso farmacéutico o un solvato aceptable para uso farmacéutico de dicho compuesto: También se dan a conocer composiciones farmacéuticas y medicamentos que los comprenden, métodos para modular un LTR, métodos para tratar una enfermedad, y una composición inmunogénica. Los compuestos son útiles como adyuvantes para mejorar la efectividad de una vacuna.A compound of the formula (IA), or a salt acceptable for pharmaceutical use or a solvate acceptable for pharmaceutical use of said compound: Pharmaceutical compositions and medicaments comprising them, methods for modulating an LTR, methods for treating a compound are also disclosed. disease, and an immunogenic composition. The compounds are useful as adjuvants to improve the effectiveness of a vaccine.

CU2010000176A 2009-02-27 2010-09-03 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF TLR ACTIVITY CU23948B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2009/035563 WO2009111337A1 (en) 2008-03-03 2009-02-27 Compounds and compositions as tlr activity modulators

Publications (2)

Publication Number Publication Date
CU20100176A7 CU20100176A7 (en) 2011-10-31
CU23948B1 true CU23948B1 (en) 2013-10-29

Family

ID=45000130

Family Applications (1)

Application Number Title Priority Date Filing Date
CU2010000176A CU23948B1 (en) 2009-02-27 2010-09-03 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF TLR ACTIVITY

Country Status (2)

Country Link
CU (1) CU23948B1 (en)
TN (1) TN2010000398A1 (en)

Also Published As

Publication number Publication date
CU20100176A7 (en) 2011-10-31
TN2010000398A1 (en) 2011-12-29

Similar Documents

Publication Publication Date Title
CO6741228A2 (en) Neprilysin Inhibitors
EA201200406A1 (en) COMPOUNDS AND COMPOSITIONS THAT ARE TLR ACTIVITY MODULATORS
CO6470847A2 (en) AMINO-PROPIONIC DERIVATIVES REPLACED AS NEPRILISINE INHIBITORS
BR112013013950A2 (en) polycyclic lpa1 antagonist and uses thereof
ECSP12011799A (en) ESPIROPIPERIDINE AND PHARMACEUTICAL USE OF THE SAME COMPOUNDS
BR112012026951A2 (en) AMINO-PYRIDAZINE COMPOUNDS USEFUL IN MODULATING SKELETAL MUSCLE CONTRACTILITY, PHARMACEUTICAL COMPOSITIONS AND USE OF THE COMPOUNDS
CO6592102A2 (en) Fused tricyclic silyl compounds and methods of use thereof for the treatment of viral diseases
CO6430456A2 (en) AMINOTETRALINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USES IN THERAPY
ECSP14013217A (en) 4-IMIDAZOPIRIDAZIN-1-IL-BENZAMIDAS AND 4-IMIDAZOTRIAZIN-1-IL-BENZAMIDAS AS BTK INHIBITORS.
CR11455A (en) NEW CYCL HYDROCARBON COMPOUNDS FOR THE TREATMENT OF DISEASES
CU20110216A7 (en) AMINOBUTYRIC DERIVATIVES REPLACED AS NEPRILISINE INHIBITORS
UY30438A1 (en) N-SUBSTITUTED DERIVATIVES OF 5-HALO-4- [2-RENT-1-SUBSTITUTES-1H-IMIDAZOL-5-IL] PIRIMIDIN-2-AMINA, COMPOSITIONS-PROCESSES FOR PREPARATION AND USES
EA201590358A1 (en) Inhibitors of Human Immunodeficiency Virus Replication
MX342212B (en) Substituted aminobutyric derivatives as neprilysin inhibitors.
BR112015022096A8 (en) sodium channel modulating compounds, composition comprising them and use thereof
CO6630154A2 (en) Certain amino-pyridazines, compositions thereof and methods of use of pampering
BR112013007696A2 (en) compound, pharmaceutical composition, uses of said compound and said composition
EA201692167A1 (en) MODULATORS OF TOLL-SECONDARY RECEPTORS
UY33183A (en) INHIBITING COMPOUNDS OF VIRUS FLAVIVIRIDAE, PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM AND ITS USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT
UY29087A1 (en) ADAMANTILE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USE
CR20140144A (en) DERIVATIVES OF ESTRA-1,3,5 (10), 16-TETRAEN-3-CARBOXAMIDE, PROCEDURES FOR THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS THAT CONTAIN THEM, AS WELL AS THEIR USE FOR THE PREPARATION OF MEDICINES
CL2014003012A1 (en) Capsule formulation comprising at least one compound of formula (i), solubilized; method of administration of the formulation; use to treat a hepatitis c virus infection.
PE20151607A1 (en) ORGANIC COMPOUND FORMULATIONS
MX2018010177A (en) COMPOUNDS OF 6,7-DIHIDRO-5H-PIRAZOLO [5,1-B] [1,3] OXAZINA-2-CARBOXA MIDA.
MX2014000344A (en) TRPV1 ANTAGONISTS THAT INCLUDE SUBSTITUTE DIHIDROXI AND ITS USES.